Compare CSV & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | PCRX |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.0M | 1.0B |
| IPO Year | 1996 | 2011 |
| Metric | CSV | PCRX |
|---|---|---|
| Price | $42.78 | $26.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $59.00 | $32.86 |
| AVG Volume (30 Days) | 69.2K | ★ 869.1K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ 3.09 | 0.47 |
| Revenue | $409,658,000.00 | ★ $716,791,000.00 |
| Revenue This Year | $3.81 | $6.24 |
| Revenue Next Year | $3.37 | $9.53 |
| P/E Ratio | ★ $13.91 | $55.29 |
| Revenue Growth | 1.07 | ★ 3.14 |
| 52 Week Low | $35.51 | $18.17 |
| 52 Week High | $49.41 | $27.64 |
| Indicator | CSV | PCRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 59.81 |
| Support Level | $42.79 | $25.56 |
| Resistance Level | $44.45 | $27.16 |
| Average True Range (ATR) | 0.99 | 1.00 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 44.80 | 69.03 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.